Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

被引：0

作者：

Buisson, A. ^{[1
]}

Nachury, M. ^{[2
]}

Fumery, M. ^{[3
]}

Guilmoteau, T. ^{[1
]}

Leclerc, E. ^{[1
]}

Altwegg, R. ^{[4
]}

Serrero, M. ^{[5
]}

Mathieu, N. ^{[6
]}

Treton, X. ^{[7
]}

Vuitton, L. ^{[8
]}

Pereira, B. ^{[9
]}

Amiot, A. ^{[10
]}

Bouguen, G. ^{[11
]}

机构：

[1] Univ Hosp Estaing, Dept Gastroenterol, IBD Unit, Clermont Ferrand, France

[2] CHRU Lille, IBD Unit, Lille, France

[3] CHU Amiens, IBD Unit, Amiens, France

[4] CHU Montpellier, IBD Unit, Montpellier, France

[5] AP HM, IBD Unit, Marseille, France

[6] CHU Grenoble, IBD Unit, Grenoble, France

[7] AP HP Beaujon Hosp, IBD Unit, Paris, France

[8] CHU Besancon, IBD Unit, Besancon, France

[9] Univ Hosp Estaing, DRCI Biostat Unit, Clermont Ferrand, France

[10] AP HP Creteil Hosp, IBD Unit, Paris, France

[11] CHU Rennes, IBD Unit, Rennes, France

来源：

JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

DOP76

引用

页码：I120 / I120

页数：1

共 50 条

[1] REAL-WORLD MULTICENTER COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT
Buisson, Anthony
Nachury, Maria
Fumery, Mathurin
Guilmoteau, Thomas
Leclerc, Eloise
Altwegg, Romain
Serrero, Melanie
Mathieu, Nicolas
Treton, Xavier
Vuitton, Lucine
Pereira, Bruno
Amiot, Aurelien
Bouguen, Guillaume
GASTROENTEROLOGY, 2022, 162 (07) : S604 - S604
[2] Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent
Buisson, Anthony
Nachury, Maria
Guilmoteau, Thomas
Altwegg, Romain
Treton, Xavier
Fumery, Mathurin
Serrero, Melanie
Leclerc, Eloise
Caillo, Ludovic
Pereira, Bruno
Amiot, Aurelien
Bouguen, Guillaume
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (06) : 676 - 688
[3] Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent
Fumery, Mathurin
Serrero, Melanie
Bouguen, Guillaume
Amiot, Aurelien
Altwegg, Romain
Nachury, Maria
Vuitton, Lucine
Treton, Xavier
Caillo, Ludovic
Pereira, Bruno
Buisson, Antony
JOURNAL OF CROHNS & COLITIS, 2024,
[4] Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study
Buisson, A.
Serrero, M.
Altwegg, R.
Guilmoteau, T.
Bouguen, G.
Nachury, M.
Amiot, A.
Vuitton, L.
Treton, X.
Caillo, L.
Pereira, B.
Fumery, M.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 707 - 707
[5] REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: RESULTS FROM THE TORUS STUDY
Buisson, Anthony
Serrero, Melanie
Altwegg, Romain
Guilmoteau, Thomas
Guillaume, Bouguen
Nachury, Maria
Amiot, Aurelien
Vuitton, Lucine
Treton, Xavier
Caillo, Ludovic
Pereira, Bruno
Fumery, Mathurin
GASTROENTEROLOGY, 2023, 164 (06) : S4 - S4
[6] Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure?
Ernest-Suarez, Kenneth
Lu, Cathy
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (06) : 733 - 734
[7] Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis
Adimadhyam, Sruthi
Lewis, James D.
Simon, Andrew L.
Wolfe, Audrey E.
Smith, Samantha
Hou, Laura
Moyneur, Erick
Reynolds, Juliane S.
Toh, Sengwee
Dobes, Angela
Parlett, Lauren
Haynes, Kevin
Burris, Jessica
Dorand, Jennifer E.
Long, Millie D.
Kappelman, Michael D.
INFLAMMATORY BOWEL DISEASES, 2024, 30 (04) : 554 - 562
[8] Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure? Authors' reply
Buisson, Anthony
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (06) : 735 - 736
[9] TREATMENT PERSISTENCE RATES WITH TOFACITINIB IN A REAL-WORLD COHORT OF ANTI-TNF REFRACTORY ULCERATIVE COLITIS PATIENTS
Conley, Thomas
Colclough, James
Liu, Eleanor
Razanskaite, Violeta
Jakobek, William
Limdi, Jimmy
Flanagan, Paul
Subramanian, Sreedhar
GUT, 2021, 70 : A88 - A89
[10] REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF IN BIOLOGIC-NAIVE ULCERATIVE COLITIS PATIENTS: RESULTS FROM THE EVOLVE STUDY
Yarur, Andres J.
Mantzaris, Gerassimos J.
Silverberg, Mark S.
Walshe, Margaret
Zezos, Petros
Stein, Dara
Bassel, Marielle
Lissoos, Trevor
Lopez, Claudia
Natsios, Athanasios
Radulescu, Gabriela
Patel, Haridarshan
Demuth, Dirk
Bressler, Brian
GASTROENTEROLOGY, 2019, 156 (06) : S637 - S638

← 1 2 3 4 5 →